|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zeng H, Zheng R, Guo Y, Zhang S, Zou X,
Wang N, Zhang L, Tang J, Chen J, Wei K, et al: Cancer survival in
China, 2003–2005: A population-based study. Int J Cancer.
136:1921–1930. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen MJ, Chiou YY, Wu DC and Wu SL:
Lifestyle habits and gastric cancer in a hospital-based
case-control study in taiwan. Am J Gastroenterol. 95:3242–3249.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bujanda L: The effects of alcohol
consumption upon the gastrointestinal tract. Am J Gastroenterol.
95:3374–3382. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Torre LA, Sauer AM, Chen MS Jr,
Kagawa-Singer M, Jemal A and Siegel RL: Cancer statistics for asian
americans, native hawaiians, and pacific islanders, 2016:
Converging incidence in males and females. CA Cancer J Clin.
66:182–202. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Boffetta P and Hashibe M: Alcohol and
cancer. Lancet Oncol. 7:149–156. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Seitz HK and Stickel F: Molecular
mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer.
7:599–612. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hashibe M, McKay JD, Curado MP, Oliveira
JC, Koifman S, Koifman R, Zaridze D, Shangina O, Wünsch-Filho V,
Eluf-Neto J, et al: Multiple ADH genes are associated with upper
aerodigestive cancers. Nat Genet. 40:707–709. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu C, Kraft P, Zhai K, Chang J, Wang Z, Li
Y, Hu Z, He Z, Jia W, Abnet CC, et al: Genome-wide association
analyses of esophageal squamous cell carcinoma in chinese identify
multiple susceptibility loci and gene-environment interactions. Nat
Genet. 44:1090–1097. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wei RR, Zhang MY, Rao HL, Pu HY, Zhang HZ
and Wang HY: Identification of ADH4 as a novel and potential
prognostic marker in hepatocellular carcinoma. Med Oncol.
29:2737–2743. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jelski W, Mroczko B and Szmitkowski M: The
diagnostic value of alcohol dehydrogenase (ADH) isoenzymes and
aldehyde dehydrogenase (ALDH) measurement in the sera of colorectal
cancer patients. Dig Dis Sci. 55:2953–2957. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jelski W, Laniewska-Dunaj M, Niklinski J,
Kozlowski M, Laudanski J and Szmitkowski M: The alcohol
dehydrogenase isoenzyme (ADH IV) as a candidate tumour marker of
esophageal cancer. Acta Biochim Pol. 60:489–493. 2013.PubMed/NCBI
|
|
14
|
Jelski W, Orywal K, Laniewska M and
Szmitkowski M: The diagnostic value of alcohol dehydrogenase (ADH)
isoenzymes and aldehyde dehydrogenase (ALDH) measurement in the
sera of gastric cancer patients. Clin Exp Med. 10:215–219. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jelski W and Szmitkowski M: Alcohol
dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) in the cancer
diseases. Clin Chim Acta. 395:1–5. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lánczky A, Nagy Á, Bottai G, Munkácsy G,
Szabó A, Santarpia L and Győrffy B: miRpower: A web-tool to
validate survival-associated miRNAs utilizing expression data from
2178 breast cancer patients. Breast Cancer Res Treat. 160:439–446.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Györffy B, Lanczky A, Eklund AC, Denkert
C, Budczies J, Li Q and Szallasi Z: An online survival analysis
tool to rapidly assess the effect of 22,277 genes on breast cancer
prognosis using microarray data of 1,809 patients. Breast Cancer
Res Treat. 123:725–731. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gyorffy B, Lanczky A and Szallasi Z:
Implementing an online tool for genome-wide validation of
survival-associated biomarkers in ovarian-cancer using microarray
data from 1287 patients. Endocr Relat Cancer. 19:197–208. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gyorffy B, Surowiak P, Budczies J and
Lanczky A: Online survival analysis software to assess the
prognostic value of biomarkers using transcriptomic data in
non-small-cell lung cancer. PLoS One. 8:e822412013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Szász AM, Lánczky A, Nagy Á, Förster S,
Hark K, Green JE, Boussioutas A, Busuttil R, Szabó A and Győrffy B:
Cross-validation of survival associated biomarkers in gastric
cancer using transcriptomic data of 1,065 patients. Oncotarget.
7:49322–49333. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li K, Guo X, Wang Z, Li X, Bu Y, Bai X,
Zheng L and Huang Y: The prognostic roles of ALDH1 isoenzymes in
gastric cancer. Onco Targets Ther. 9:3405–3414. 2016.PubMed/NCBI
|
|
22
|
Dennis G Jr, Sherman BT, Hosack DA, Yang
J, Gao W, Lane HC and Lempicki RA: DAVID: Database for annotation,
visualization, and integrated discovery. Genome Biol. 4:P32003.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Warde-Farley D, Donaldson SL, Comes O,
Zuberi K, Badrawi R, Chao P, Franz M, Grouios C, Kazi F, Lopes CT,
et al: The GeneMANIA prediction server: Biological network
integration for gene prioritization and predicting gene function.
Nucleic Acids Res. 38:W214–220. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mostafavi S, Ray D, Warde-Farley D,
Grouios C and Morris Q: GeneMANIA: A real-time multiple association
network integration algorithm for predicting gene function. Genome
Biol. 9:S42008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Szklarczyk D, Franceschini A, Wyder S,
Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos
A, Tsafou KP, et al: STRING v10: Protein-protein interaction
networks, integrated over the tree of life. Nucleic Acids Res.
43:D447–452. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
von Mering C, Huynen M, Jaeggi D, Schmidt
S, Bork P and Snel B: STRING: A database of predicted functional
associations between proteins. Nucleic Acids Res. 31:258–261. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sobin LH, Gospodarowicz MK and Wittekind
CH; International Union against Cancer, : TNM classification of
malignant tumours. 7th. West Sussex; Chichester, UK: 2009
|
|
28
|
Lauren P: The two histological main types
of gastric carcinoma: Diffuse and so-called intestinal-type
carcinoma. an attempt at a histo-clinical classification. Acta
Pathol Microbiol Scand. 64:31–49. 1965. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang G, Hu N, Yang HH, Wang L, Su H, Wang
C, Clifford R, Dawsey EM, Li JM, Ding T, et al: Comparison of
global gene expression of gastric cardia and noncardia cancers from
a high-risk population in china. PLoS One. 8:e638262013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
R Development Core Team: R, . A language
and environment for statistical computing. R Foundation for
Statistical Computing; Vienna: 2008
|
|
31
|
Druesne-Pecollo N, Tehard B, Mallet Y,
Gerber M, Norat T, Hercberg S and Latino-Martel P: Alcohol and
genetic polymorphisms: Effect on risk of alcohol-related cancer.
Lancet Oncol. 10:173–180. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Klyosov AA: Kinetics and specificity of
human liver aldehyde dehydrogenases toward aliphatic, aromatic, and
fused polycyclic aldehydes. Biochemistry. 35:4457–4467. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Crabb DW, Bosron WF and Li TK: Ethanol
metabolism. Pharmacol Ther. 34:59–73. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Seitz HK and Oneta CM: Gastrointestinal
alcohol dehydrogenase. Nutr Rev. 56:52–60. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Holmes RS: Alcohol dehydrogenases: A
family of isozymes with differential functions. Alcohol Alcohol
Suppl. 2:127–130. 1994.PubMed/NCBI
|
|
36
|
Holmes R: Alcohol dehydrogenases: Gene
multiplicity and differential functions of five classes of
isozymes. Drug Alcohol Rev. 12:99–110. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Orywal K and Szmitkowski M: Alcohol
dehydrogenase and aldehyde dehydrogenase in malignant neoplasms.
Clin Exp Med. 17:131–139. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Orywal K, Jelski W, Werel T and
Szmitkowski M: The diagnostic significance of serum alcohol
dehydrogenase isoenzymes and aldehyde dehydrogenase activity in
renal cell cancer patients. Exp Mol Pathol. 100:416–420. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Orywal K, Jelski W, Zdrodowski M and
Szmitkowski M: The diagnostic value of alcohol dehydrogenase
isoenzymes and aldehyde dehydrogenase measurement in the sera of
patients with endometrial cancer. Anticancer Res. 33:3725–3730.
2013.PubMed/NCBI
|
|
40
|
Jelski W, Laniewska-Dunaj M, Orywal K,
Kochanowicz J, Rutkowski R and Szmitkowski M: The diagnostic value
of alcohol dehydrogenase (ADH) isoenzymes and aldehyde
dehydrogenase (ALDH) measurement in the sera of patients with brain
tumor. Arch Med Sci. 13:346–352. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Jelski W, Laniewska-Dunaj M, Orywal K,
Kochanowicz J, Rutkowski R and Szmitkowski M: The activity of
alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase
(ALDH) in the sera of patients with brain cancer. Neurochem Res.
39:2313–2318. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Orywal K, Jelski W, Zdrodowski M and
Szmitkowski M: The diagnostic value of alcohol dehydrogenase
isoenzymes and aldehyde dehydrogenase measurement sera of cervical
cancer patients. Anticancer Res. 36:2265–2269. 2016.PubMed/NCBI
|
|
43
|
Jelski W, Kutylowska E, Laniewska-Dunaj M
and Szmitkowski M: Alcohol dehydrogenase (ADH) and aldehyde
dehydrogenase (ALDH) as candidates for tumor markers in patients
with pancreatic cancer. J Gastrointestin Liver Dis. 20:255–259.
2011.PubMed/NCBI
|
|
44
|
Jelski W, Zalewski B and Szmitkowski M:
Alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase
(ALDH) activity in the sera of patients with liver cancer. J Clin
Lab Anal. 22:204–209. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Jelski W, Kozlowski M, Laudanski J,
Niklinski J and Szmitkowski M: Alcohol dehydrogenase isoenzymes and
aldehyde dehydrogenase activity in the sera of patients with
esophageal cancer. Clin Exp Med. 9:131–137. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Orywal K, Jelski W, Werel T and
Szmitkowski M: The activity of class I, II, III and IV alcohol
dehydrogenase isoenzymes and aldehyde dehydrogenase in the sera of
bladder cancer patients. Acta Biochim Pol. 64:81–84. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Orywal K, Jelski W, Zdrodowski M and
Szmitkowski M: The activity of class I, II, III and IV alcohol
dehydrogenase isoenzymes and aldehyde dehydrogenase in cervical
cancer. Clin Biochem. 44:1231–1234. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Orywal K, Jelski W, Zdrodowski M and
Szmitkowski M: The activity of class I, II, III and IV alcohol
dehydrogenase isoenzymes and aldehyde dehydrogenase in ovarian
cancer and ovarian cysts. Adv Med Sci. 58:216–220. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Orywal K, Jelski W, Zdrodowski M and
Szmitkowski M: The activity of class I, II, III, and IV alcohol
dehydrogenase isoenzymes and aldehyde dehydrogenase in endometrial
cancer. J Clin Lab Anal. 24:334–339. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Laniewska-Dunaj M, Jelski W, Orywal K,
Kochanowicz J, Rutkowski R and Szmitkowski M: The activity of class
I, II, III and IV of alcohol dehydrogenase (ADH) isoenzymes and
aldehyde dehydrogenase (ALDH) in brain cancer. Neurochem Res.
38:1517–1521. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Jelski W, Zalewski B and Szmitkowski M:
The activity of class I, II, III, and IV alcohol dehydrogenase
(ADH) isoenzymes and aldehyde dehydrogenase (ALDH) in liver cancer.
Dig Dis Sci. 53:2550–2555. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Jelski W, Zalewski B, Chrostek L and
Szmitkowski M: Alcohol dehydrogenase (ADH) isoenzymes and aldehyde
dehydrogenase (ALDH) activity in the sera of patients with
colorectal cancer. Clin Exp Med. 7:154–157. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Jelski W, Zalewski B, Chrostek L and
Szmitkowski M: The activity of class I, II, III, and IV alcohol
dehydrogenase isoenzymes and aldehyde dehydrogenase in colorectal
cancer. Dig Dis Sci. 49:977–981. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Orywal K, Jelski W, Werel T and
Szmitkowski M: The activity of class I, II, III and IV alcohol
dehydrogenase isoenzymes and aldehyde dehydrogenase in renal cell
carcinoma. Exp Mol Pathol. 98:403–406. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Jelski W, Chrostek L, Szmitkowski M and
Markiewicz W: The activity of class I, II, III and IV alcohol
dehydrogenase isoenzymes and aldehyde dehydrogenase in breast
cancer. Clin Exp Med. 6:89–93. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Jelski W, Chrostek L and Szmitkowski M:
The activity of class I, II, III, and IV of alcohol dehydrogenase
isoenzymes and aldehyde dehydrogenase in pancreatic cancer.
Pancreas. 35:142–146. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Jelski W, Kozlowski M, Laudanski J,
Niklinski J and Szmitkowski M: The activity of class I, II, III,
and IV alcohol dehydrogenase (ADH) isoenzymes and aldehyde
dehydrogenase (ALDH) in esophageal cancer. Dig Dis Sci. 54:725–730.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Shang L, Zhu G, Su H, Chen B, Ye X, Chen
X, Xiao K, Li L, Peng M and Peng T: Identification of alcohol
dehydrogenase as a potential prognostic marker in HBV-related
hepatocellular carcinoma. Int J Clin Exp Med. 10:4457–4472.
2017.
|
|
59
|
Li D, Zhang R, Jin T, He N, Ren L, Zhang
Z, Zhang Q, Xu R, Tao H, Zeng G and Gao J: ADH1B and CDH1
polymorphisms predict prognosis in male patients with
non-metastatic laryngeal cancer. Oncotarget. 7:73216–73228.
2016.PubMed/NCBI
|
|
60
|
Jiang W, Jin Z, Zhou F, Cui J and Wang L
and Wang L: High co-expression of Sp1 and HER-2 is correlated with
poor prognosis of gastric cancer patients. Surg Oncol. 24:220–225.
2015. View Article : Google Scholar : PubMed/NCBI
|
